Pralatrexate Is Effective as Second-Line Treatment Following Cyclophosphamide/Doxorubicin/Vincristine/Prednisone (CHOP) Failure In Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma (PTCL)
Year: 2010
Type: article
Source: Blood
Institutions: University of Washington, Fox Chase Cancer Center, Hôpital Saint-Louis, Laboratoire d'hématologie, City Of Hope National Medical Center, City of Hope, Washington University in St. Louis, Emory University, Winship Cancer Institute, NYU Langone Health, New York University, University of Rochester Medicine, University of Rochester, Cornell University, Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2558528113